Wall Street Downgrades Hershey, Intuit, Medtronic: Have Retail Traders Turned Bearish?

A series of downgrades from prominent Wall Street analysts has cast a dark cloud over Hershey, Intuit and Medtronic. Let’s take a closer look at how retail investors are reacting: 

Hershey (HSY): Chocolate giant Hershey has found itself in a challenging position. Argus Research downgraded the company from ‘Buy’ to ‘Hold’, citing disappointing Q2 earnings and revenue, coupled with rising input costs and shifting consumer preferences. 

The analyst firm believes that consumers' increasing focus on value and reduced store visits, as highlighted by Hershey's management, necessitate a more cautious stance.

While Hershey's stock experienced a slight uptick today, retail sentiment on Stocktwits remains lukewarm, at neutral levels (48/100), from a week ago, suggesting ongoing investor uncertainty. Hershey CEO Michele Buck has acknowledged the "dynamic” operating environment “with consumers pulling back on discretionary spending.”

Intuit (INTU): A leading financial software provider, Intuit has faced some headwinds. Morgan Stanley analyst Keith Weiss downgraded the company from ‘Overweight’ to ‘Equal Weight,’ expressing concerns about the company's pricing strategy and the integration of recent acquisitions, namely Credit Karma and Mailchimp. 

Weiss believes that aggressive pricing may be contributing to market share losses for TurboTax.
The market reacted negatively to the downgrade, with Intuit's stock price declining, and retail sentiment flipped from ‘neutral’ (48/100) to ‘bullish’ (58/100) in a day.

The company's decision to lay off employees and close certain operations to invest in generative AI underscores the challenges it faces in maintaining its growth trajectory.

Medtronic (MDT): Medical device manufacturer Medtronic has also encountered difficulties. Stifel downgraded the company from "Buy" to "Hold," citing slower-than-expected innovation pipeline development and intensifying competition. 

While acknowledging CEO Geoff Martha's efforts to steer the company in the right direction, Stifel expressed concerns about the pace of progress.

Despite an improvement in retail sentiment on Stocktwits, from ‘neutral’ (48/100) to ‘bullish’ (58/100) in a day, Medtronic's stock price has underperformed this year. The company's upcoming Q1 earnings report on Aug. 20 will be closely watched by investors to assess its ability to address the challenges outlined by Stifel.